Home
Taro Pharmaceuticals

Taro Pharmaceuticals Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domaintaro.com

Year Founded1950

Employees1001 - 5000

Annual Revenue$500M - $1B

Taro Pharmaceuticals

Taro Pharmaceuticals (including company regionals)

taro.com

See more website traffic and engagement information

Taro Pharmaceuticals Revenue up to May 2026 is 500M - 1B

revenue generated by Taro Pharmaceuticals top domains

Taro Pharmaceuticals top domains revenue over 3 years

Revenue for Taro Pharmaceuticals top domains

taro.com500M - 1B

See more with Sales Intelligence

Total visits to Taro Pharmaceuticals's top domains

Understand Taro Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

taro.com23.7K

See more with Sales Intelligence

Avg. visit duration in Taro Pharmaceuticals's top domains

Analyze Taro Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

taro.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Taro Pharmaceuticals's top domains

See how Taro Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

taro.com1.61

See more with Sales Intelligence

Taro Pharmaceuticals top competitors by domain

Top similar sites in May 2026, ranked by their affinity

medochemie.comCompany NameMedochemieEmployees1001 - 5000HQCyprus, LimassolAnnual revenue$200M - $500MTotal visits5.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Taro Pharmaceuticals

These are the website technologies, by industry, used by Taro Pharmaceuticals top domains

Content Management System (2)

Drupal

Payment & Currencies (2)

Euro

Widget (2)

General Captcha

Advertising (1)

PubMatic

More Technologies

5

See all

News & Signals from Taro Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTaro Pharmaceutical Industries Ltd. has issues with violations of the federal securities laws.LOS ANGELES-(BUSINESS WIRE)-The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE: TARO) for violations of the federal securities laws.

NewsSUN acquired Taro Pharmaceutical Industries Ltd. on Jan 1st '07.Sun's first attempt to acquire Taro came back in 2007, and the company had to sweeten its latest offer to win over Taro.